Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Improving Cardiovascular Health

Improving Cardiovascular Health VIEWPOINT ONLINE FIRST A Balance Between Discovery and Delivery viate or minimize the need for dual antiplatelet therapy. New William A. Zoghbi, MD strategies for treatment of hypertension are also the focus David R. Holmes Jr, MD of intense study. Early data on the use of radiofrequency re- nal artery sympathetic denervation, based on this type of HE PAST 30 YEARS HAVE SEEN MAJOR SHIFTS IN CAR- treatment in electrophysiology, are promising. Manage- diovascular science and medicine. In the United ment of hypertension in patients with advanced disease may States, mortality due to cardiovascular disease (CVD) therefore substantially change in the next few years. Thas declined by more than 60% as a result of new Structural heart disease has also become a focus, with new therapeutic approaches, including the introduction of stat- percutaneous devices to occlude or obliterate the left atrial ins, better anticoagulants, angiotensin-converting enzyme appendage (a source of emboli in atrial fibrillation), and trans- inhibitors, devices such as implantable cardioverter- cutaneous replacement of the cardiac valves. Aortic and pul- defibrillators, and—perhaps foremost—the application of monary transcatheter valves are used with increased fre- evidence-based scientific guidelines. There is every rea- quency; mitral and tricuspid valves are currently undergoing http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Improving Cardiovascular Health

JAMA , Volume 309 (11) – Mar 20, 2013

Loading next page...
 
/lp/american-medical-association/improving-cardiovascular-health-I5mCX00AgQ
Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2013.2416
pmid
23475314
Publisher site
See Article on Publisher Site

Abstract

VIEWPOINT ONLINE FIRST A Balance Between Discovery and Delivery viate or minimize the need for dual antiplatelet therapy. New William A. Zoghbi, MD strategies for treatment of hypertension are also the focus David R. Holmes Jr, MD of intense study. Early data on the use of radiofrequency re- nal artery sympathetic denervation, based on this type of HE PAST 30 YEARS HAVE SEEN MAJOR SHIFTS IN CAR- treatment in electrophysiology, are promising. Manage- diovascular science and medicine. In the United ment of hypertension in patients with advanced disease may States, mortality due to cardiovascular disease (CVD) therefore substantially change in the next few years. Thas declined by more than 60% as a result of new Structural heart disease has also become a focus, with new therapeutic approaches, including the introduction of stat- percutaneous devices to occlude or obliterate the left atrial ins, better anticoagulants, angiotensin-converting enzyme appendage (a source of emboli in atrial fibrillation), and trans- inhibitors, devices such as implantable cardioverter- cutaneous replacement of the cardiac valves. Aortic and pul- defibrillators, and—perhaps foremost—the application of monary transcatheter valves are used with increased fre- evidence-based scientific guidelines. There is every rea- quency; mitral and tricuspid valves are currently undergoing

Journal

JAMAAmerican Medical Association

Published: Mar 20, 2013

References